Incyte: Riding Jakafi, Bracing For Generic Headwinds (NASDAQ:INCY)

In my opinion, Incyte Corporation ( INCY ) is one of the most interesting businesses in biopharmaceuticals for fans of value investing. High revenue growth rates, high business margins compared to sectoral competitors, and aHi there! I’m Narek, and I’ve been in the investment world for over six years. I started out as an equity analyst at European banks, digging into reports and learning how to spot value in the markets. I’ve worked across sectors — from telecom to industry — and found that behind every fin ...